Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Farmaco (Societa Chimica Italiana : 1989)
|
July 27, 1999
Ergoline derivatives: receptor affinity and selectivity
S Mantegani, E Brambilla, M Varasi
Neurochemistry International
|
March 1, 1992
A new dopamine agonist in dopamine deprived systems: FCE 23884
M Buonamici, M A Cervini, R Maj, et al.
Annals of the New York Academy of Sciences
|
May 30, 1997
13-Tert-butylergoline derivatives. Assessment of functional serotonergic 5-HT1A component
M G Fornaretto, C Caccia, G Marchi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 1, 1993
Disposition and urinary metabolic pattern of cabergoline, a potent dopaminergic agonist, in rat, monkey and man
R Battaglia, M Strolin Benedetti, S Mantegani, et al.
Drug Design and Delivery
|
May 1, 1987
Antihypertensive ergoline derivatives
S Mantegani, A Temperilli, G Traquandi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Serotonergic ergoline derivatives
S Mantegani, E Brambilla, C Caccia, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
July 11, 1998
Synthesis and antihypertensive activity of 2,4-dioxoimidazolidin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives
S Mantegani, E Brambilla, C Caccia, et al.
Arzneimittel-Forschung
|
January 1, 1983
Antihypertensive ergolinepropionamides
L Bernardi, G Bosisio, S Mantegani, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
April 17, 1998
Synthesis and in vitro and in vivo evaluation of dopaminergic ergoline derivatives
S Mantegani, E Brambilla, C Caccia, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies
N Carfagna, C Caccia, S Mantegani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Farmaco (Societa Chimica Italiana : 1989)
|
July 27, 1999
Ergoline derivatives: receptor affinity and selectivity
S Mantegani, E Brambilla, M Varasi
Neurochemistry International
|
March 1, 1992
A new dopamine agonist in dopamine deprived systems: FCE 23884
M Buonamici, M A Cervini, R Maj, et al.
Annals of the New York Academy of Sciences
|
May 30, 1997
13-Tert-butylergoline derivatives. Assessment of functional serotonergic 5-HT1A component
M G Fornaretto, C Caccia, G Marchi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 1, 1993
Disposition and urinary metabolic pattern of cabergoline, a potent dopaminergic agonist, in rat, monkey and man
R Battaglia, M Strolin Benedetti, S Mantegani, et al.
Drug Design and Delivery
|
May 1, 1987
Antihypertensive ergoline derivatives
S Mantegani, A Temperilli, G Traquandi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Serotonergic ergoline derivatives
S Mantegani, E Brambilla, C Caccia, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
July 11, 1998
Synthesis and antihypertensive activity of 2,4-dioxoimidazolidin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives
S Mantegani, E Brambilla, C Caccia, et al.
Arzneimittel-Forschung
|
January 1, 1983
Antihypertensive ergolinepropionamides
L Bernardi, G Bosisio, S Mantegani, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
April 17, 1998
Synthesis and in vitro and in vivo evaluation of dopaminergic ergoline derivatives
S Mantegani, E Brambilla, C Caccia, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies
N Carfagna, C Caccia, S Mantegani, et al.
Page
of 2